NYSE:LLY

Eli Lilly and Company

Stock

USD

Last Close

750.77

18/04 20:00

Market Cap

709.22B

Beta: 0.36

Volume Today

1.70M

Avg: 3.30M

PE Ratio

127.25

PFCF: −4,061.24

Dividend Yield

0.64%

Payout:78.90%

Overview Financials Filings timeline analysis people Ownership API Chart

locale
United States
market
STOCKS
industry
Drug Manufacturers / General
website
www.lilly.com
crunchbase
eli-lilly
ipo date
Jun 01, 1972

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

NYSE:LLY

Eli Lilly and Company

Last Close

750.77

18/04 20:00

Market Cap

709.22B

Beta: 0.36

Volume Today

1.70M

Avg: 3.30M

PE Ratio

127.25

PFCF: −4,061.24

Dividend Yield

0.64%

Payout:78.90%

locale

market

industry

website

crunchbase

ipo date

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics

Please Sign In To Use The Chat